NPR politics and science correspondents answer listener questions about the federal government response to the coronavirus and the possibility that as many as 100,000 Americans could be killed by it.
As head of the Centers for Medicare and Medicaid Services, Verma says she's working to ease safety rules and lighten licensing requirements, to expand the number of hospital beds and health workers.
With a lack of tests, epidemiologists say the next best way to monitor the pandemic is by tracking hospitalizations. But hotspots like California and Washington are releasing little information.
On-site testing was delayed for weeks at a Brooklyn hospital that has been designated COVID-19 only. Rapid on-site testing can help hospitals prevent the virus from spreading inside their facilities.
The Department of Health and Human Services outlines support for Moderna and Johnson & Johnson, as the companies work to develop coronavirus vaccines. Beefing up manufacturing capacity is a priority.
Aetna, Cigna and Humana now say they will waive most treatment costs associated with COVID-19 that would normally be picked up by patients enrolled in their health plans. Will other firms follow suit?
Dr. Robert Redfield, head of the U.S. Centers for Disease Control and Prevention, recently spoke with Sam Whitehead of member station WABE. Whitehead speaks with NPR's Ailsa Chang.
Chloroquine and hydroxycloroquine got the Food and Drug Administration's go-ahead to be put in the nation's strategic storehouses. But the drugs haven't been approved to treat coronavirus patients.